Bicara Therapeutics Inc (BCAX)

Other Income/Expenses (Net)

$4.58M

Quarterly · Period ending: · USD

BCAX logo

BCAX Other Income/Expenses (Net)

Latest reported$4.58M
BCAX Quarterly Other Income/Expenses (Net) (-$14.00K → $4.58M)
High-resolution chart · PNG

BCAX other income/expenses (net) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Bicara Therapeutics Inc Other Income/Expenses (Net) — Quarterly (USD)
Period endingOther Income/Expenses (Net) (USD)
4,576,000
4,083,000
3,789,000
4,386,000
4,682,000
5,014,000
5,866,000
3,147,000
2,701,000
2,867,000
1,252,000
-13,315,000
-14,000
-14,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.